Obstructive Pulmonary Disease Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Obstructive Pulmonary Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 208 trials

Recruiting
Phase 4

A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation

Chronic Obstructive Pulmonary DiseaseHyperinflation
AstraZeneca56 enrolled6 locationsNCT07073950
Recruiting

IMPACT COPD Cohort (China)

Chronic Obstructive Pulmonary Disease (COPD)Multimorbidities
Beijing Chao Yang Hospital10,000 enrolled4 locationsNCT07382986
Recruiting
Phase 4

Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)

Chronic Obstructive Pulmonary Disease (COPD)
Copenhagen Respiratory Research2,000 enrolled14 locationsNCT06892210
Recruiting

Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes

Chronic Obstructive Pulmonary Disease (COPD)
Sanofi500 enrolled20 locationsNCT07380711
Recruiting
Phase 2

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca1,160 enrolled363 locationsNCT07082738
Recruiting

Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo

Chronic Obstructive Pulmonary Disease
AstraZeneca1,400 enrolled12 locationsNCT07069829
Recruiting

University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2

Smoking, CigaretteCOPD, Chronic Obstructive Pulmonary DiseaseCancer Lung Screening
University of Michigan200 enrolled1 locationNCT07482475
Recruiting

Study of Patient With Frequent Exacerbations in Moscow

Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca500 enrolled1 locationNCT07307781
Recruiting

Investigation and Classification of Treatable Traits in Patients With Chronic Airway Diseases

Chronic Obstructive Pulmonary Disease (COPD)Asthma (Diagnosis)Chronic Airway Diseases
Beijing Chao Yang Hospital950 enrolled1 locationNCT07472738
Recruiting
Not Applicable

OMEGA - Dietary Intervention - COPD Trial

COPD, Chronic Obstructive Pulmonary Disease
Johns Hopkins University200 enrolled1 locationNCT05297279
Recruiting
Phase 1Phase 2

A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

Chronic Obstructive Pulmonary DiseaseNon-cystic Fibrosis Bronchiectasis
Genentech, Inc.128 enrolled7 locationsNCT06603246
Recruiting
Phase 1Phase 2

cfMSC Stem Cell Therapy Targeting COPD

Chronic Obstructive Pulmonary Disease (COPD)
Shenzhen Geno-Immune Medical Institute30 enrolled1 locationNCT07477600
Recruiting
Not Applicable

Different Inspiratory Muscle Trainings in Patients With COPD

Chronic Obstructive Pulmonary Disease
University of Yalova51 enrolled1 locationNCT07406659
Recruiting
Not Applicable

Effects Of Low-Load Blood Flow Restriction Training Of The Upper Extremity In Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)Blood Flow Restriction Training (BFRT)
Inonu University36 enrolled1 locationNCT07469111
Recruiting

Study That Will Evaluate the Brazilian Population With COPD.

COPD, Chronic Obstructive Pulmonary Disease
AstraZeneca693 enrolled10 locationsNCT06780046
Recruiting

Predicting Risk Factors for Exacerbation of Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine200 enrolled1 locationNCT03450603
Recruiting
Phase 1

A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects

Chronic Obstructive Pulmonary Disease
Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.57 enrolled1 locationNCT07267130
Recruiting
Not Applicable

The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)

AsthmaChronic Obstructive Pulmonary DiseaseDyspnea
University of Nebraska20 enrolled1 locationNCT06524856
Recruiting

COPD Care Pathway Among Patients With Cancer

Lung CancerHead and Neck CancerChronic Obstructive Pulmonary Disease
Wake Forest University Health Sciences101 enrolled1 locationNCT05984680
Recruiting
Phase 4

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

Chronic Obstructive Pulmonary Disease
Sanofi218 enrolled48 locationsNCT07053423